Enrico Costa

6PUBLICATIONS
20CO-AUTHORS
Pharmacology and pharmaceutical sciences not elsewhere classifiedMolecular medicineBiomolecular modelling and designMolecular targetsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 31, 2026
Orphan Designation for Drugs Approved in the United States and European Union: A Comparative Analysis.

|Nov 12, 2024
Globalization in clinical drug development for sickle cell disease.

Enrico Costa, Russell E Ware, Léon Tshilolo

|Mar 24, 2024
Successes and pitfalls in orphan drug development for sickle cell disease.

Enrico Costa, Antonella Isgrò, Mariane de Montalembert

|Mar 14, 2024
Advancing rare disease treatment: EMA's decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation.

Maria Elisabeth Kalland, Tomas Pose-Boirazian, Gloria Maria Palomo

|May 07, 2022
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.

Enrico Costa, Silvia Girotti, Francesca Pauro

|Sep 25, 2020
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.

Enrico Costa, Prosper Tibalinda, Enrico Sterzi

Pageof 1

Frequent Collaborators

2 joint publications

Lucio Luzzatto

2 joint publications

Russell E Ware

2 joint publications

Hubert G M Leufkens

1 joint publications

Eliangiringa Kaale